Pharmafile Logo
Pharmafocus logo
Advanced Search
Ovarian cancer

Pfizer, Merck and Syndax in ovarian cancer trial collaboration

January 5, 2016
Manufacturing and Production, Research and Development Merck, Pfizer, Syndax Pharmaceuticals, avelumab, entinostat, ovarian cancer

Pfizer, Merck and Syndax Pharmaceuticals have announced a collaboration to test avelumab, in combination with Syndax’s entinostat, in patients with …

News
erbitux-resized

Merck’s Erbitux approved for NHS Wales

January 5, 2016
Manufacturing and Production, Sales and Marketing Erbitux, Merck, cetuximab, colorectal cancer, metastatic colorectal cancer

The All Wales Medicines Strategy Group has recommended Merck’s Erbitux in combination with chemotherapy for restricted use in the NHS …

News
AS spine fusion

Novartis’ Cosentyx shows benefits in Phase III AS trials

January 4, 2016
Research and Development, Sales and Marketing Cosentyx, Novartis, Secukinumab, ankylosing spondylitis

Novartis says results from two Phase III studies for Cosentyx in ankylosing spondylitis (AS) showing significant clinical improvements versus placebo.Results …

News
redx

Former Merck R&D expert joins RedX Pharma board

January 4, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RedX Pharma

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …

Appointment
Logos

Reports: $32bn Shire takeover of Baxalta close to done deal

January 4, 2016
Sales and Marketing Baxalta, Shire, acquisition, merger

The deal may have failed to get over the line in 2015, but reports suggest the mega merger is to …

News
pharma manufacturing

‘Rejuvenated’ pharma manufacturing set for 2016 comeback

January 4, 2016
Manufacturing and Production, Sales and Marketing Employment, industry, manufacturing, patent cliff, pharma, production

The pharma industry has been singled out for its strong performance in 2015, in a report which says manufacturing in …

News

Takeda and Teva set out generics joint venture plan

January 4, 2016
Sales and Marketing Takeda, Teva, generics, joint venture

Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …

News
NASDAQ

KaloBios files for bankruptcy after Shkreli arrest

January 4, 2016
Sales and Marketing KaloBios, Martin Shkreli

KaloBios has filed for bankruptcy in the wake of chief executive Martin Shkreli’s arrest on securities fraud charges last month …

News
Season's greetings

Season’s greetings from Pharmafocus

December 25, 2015

Merry Christmas and a happy new year from all at Pharmafocus!We will be back on Monday 4 January with all …

News
Ebola virus

WHO to review MSD’s Ebola vaccine for emergency use

December 24, 2015
Manufacturing and Production, Research and Development Ebola vaccine, Ebola virus, MSD, WHO, Zebov

The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …

News
Gavel

J&J and Purdue settle Kentucky lawsuits for $39.5 million

December 24, 2015
Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits

Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …

News
Dr Andreas Barner

Boehringer Ingelheim invests in Europe

December 24, 2015
Manufacturing and Production, Sales and Marketing Austria, Biberach, Boehringer Ingelheim, Vienna, biologicals, manufacturing, production

Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …

News
Pills image

OTC drugs market boosted by growing patient demand

December 24, 2015
Manufacturing and Production, Sales and Marketing GBI Research, OTC, generics, over the counter

Increasing pressures from customers, drug manufacturers and regulators to convert prescription medications to over-the-counter (OTC) non-prescription status is driving growth …

News
2016

Seven pharma trends for 2016

December 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2016?Pricing pressures

Feature
Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …

News
2000px-food_and_drug_administration_logo

FDA approves AstraZeneca’s gout drug Zurampic

December 23, 2015
Sales and Marketing AstraZeneca, FDA, Zurampic, gout, lensinurad

The US FDA has approved AstraZeneca’s Zurampic to treat high levels of uric acid in the blood. The drug is …

News
Janssen Velcade

NICE recommends Velcade for MCL, and three diabetes drugs

December 23, 2015
Sales and Marketing Forxiga, NICE, Velcade, invokana, jardiance, mantel cell lymphoma, mcl

NICE has published final guidance recommending Velcade (bortezomib) as a treatment for previously untreated mantle cell lymphoma (MCL).  In the …

News
melanoma cell

100 year old chemical could be the future of cancer treatment

December 23, 2015
Research and Development Cancer, PV-10, Peter Culpepper, Provectus, Rose Bengal, oncology

Peter Culpepper, chief operating officer at Provectus Biopharmaceuticals, explains the secrets of Rose Bengal, which has impressed in clinical trials …

Feature
Nucala

Researchers question price of GSK’s Nucala

December 23, 2015
Research and Development GSK, HEOR, ICER, Nucala, asthma, cost-effective, health economics, health economics outcomes research

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …

News
Bavarian Nordic logo

Janssen and Bavarian Nordic to collaborate on HPV vaccine

December 23, 2015
Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost

Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026